BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25834136)

  • 1. The bupropion-related subcortical changes in a depression patient.
    Lai CH
    Aust N Z J Psychiatry; 2015 Dec; 49(12):1224. PubMed ID: 25834136
    [No Abstract]   [Full Text] [Related]  

  • 2. Developmentally stable whole-brain volume reductions and developmentally sensitive caudate and putamen volume alterations in those with attention-deficit/hyperactivity disorder and their unaffected siblings.
    Greven CU; Bralten J; Mennes M; O'Dwyer L; van Hulzen KJ; Rommelse N; Schweren LJ; Hoekstra PJ; Hartman CA; Heslenfeld D; Oosterlaan J; Faraone SV; Franke B; Zwiers MP; Arias-Vasquez A; Buitelaar JK
    JAMA Psychiatry; 2015 May; 72(5):490-9. PubMed ID: 25785435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased subcortical volumes in alcohol dependent individuals: effect of polysubstance use disorder.
    Grodin EN; Momenan R
    Addict Biol; 2017 Sep; 22(5):1426-1437. PubMed ID: 27334243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Widespread subcortical grey matter degeneration in primary lateral sclerosis: a multimodal imaging study with genetic profiling.
    Finegan E; Li Hi Shing S; Chipika RH; Doherty MA; Hengeveld JC; Vajda A; Donaghy C; Pender N; McLaughlin RL; Hardiman O; Bede P
    Neuroimage Clin; 2019; 24():102089. PubMed ID: 31795059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral Imaging Markers of GBA and LRRK2 Related Parkinson's Disease and Their First-Degree Unaffected Relatives.
    Thaler A; Kliper E; Maidan I; Herman T; Rosenberg-Katz K; Bregman N; Gurevich T; Shiner T; Hausdorff JM; Orr-Urtreger A; Giladi N; Mirelman A
    Brain Topogr; 2018 Nov; 31(6):1029-1036. PubMed ID: 29846835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive deep gray matter volume reductions in children and adolescents with fetal alcohol spectrum disorders.
    Nardelli A; Lebel C; Rasmussen C; Andrew G; Beaulieu C
    Alcohol Clin Exp Res; 2011 Aug; 35(8):1404-17. PubMed ID: 21575012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amygdala volume is reduced in early course schizophrenia.
    Rich AM; Cho YT; Tang Y; Savic A; Krystal JH; Wang F; Xu K; Anticevic A
    Psychiatry Res Neuroimaging; 2016 Apr; 250():50-60. PubMed ID: 27035063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A 3.0 T MRI study on the alterations of the volume and morphology of fifteen subcortical nucleus in patients with early post-stroke depression].
    Chen Y; Wu MX; Gong JS; Zou LY; Xu JM; Zhu J; Li G
    Zhonghua Yi Xue Za Zhi; 2018 Aug; 98(31):2471-2475. PubMed ID: 30138997
    [No Abstract]   [Full Text] [Related]  

  • 9. Sleep Onset Problems and Subcortical Development in Infants Later Diagnosed With Autism Spectrum Disorder.
    MacDuffie KE; Shen MD; Dager SR; Styner MA; Kim SH; Paterson S; Pandey J; St John T; Elison JT; Wolff JJ; Swanson MR; Botteron KN; Zwaigenbaum L; Piven J; Estes AM
    Am J Psychiatry; 2020 Jun; 177(6):518-525. PubMed ID: 32375538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage.
    Bogerts B; Meertz E; Schönfeldt-Bausch R
    Arch Gen Psychiatry; 1985 Aug; 42(8):784-91. PubMed ID: 4015323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bupropion in the treatment of depression in Parkinson's disease.
    Załuska M; Dyduch A
    Int Psychogeriatr; 2011 Mar; 23(2):325-7. PubMed ID: 20809995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bupropion: efficacy and safety in the treatment of depression.
    Saiz Ruiz J; Gibert J; Gutiérrez Fraile M; Bobes J; Vallejo J; Iglesias C; Iriarte V
    Actas Esp Psiquiatr; 2011; 39 Suppl 1():1-25. PubMed ID: 22983817
    [No Abstract]   [Full Text] [Related]  

  • 13. Volume changes of corpus striatum, thalamus, hippocampus and lateral ventricles in posttraumatic stress disorder (PTSD) patients suffering from headaches and without therapy.
    Filipovic BR; Djurovic B; Marinkovic S; Stijak L; Aksic M; Nikolic V; Starcevic A; Radonjic V
    Cent Eur Neurosurg; 2011 Aug; 72(3):133-7. PubMed ID: 20857373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain alterations in adult ADHD: effects of gender, treatment and comorbid depression.
    Onnink AM; Zwiers MP; Hoogman M; Mostert JC; Kan CC; Buitelaar J; Franke B
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):397-409. PubMed ID: 24345721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcortical structural volumes in recently remitted first episode mania.
    Arumugham SS; Torres IJ; Lang DJ; Su W; Lam RW; Honer WG; Yatham LN
    J Affect Disord; 2017 Nov; 222():23-27. PubMed ID: 28667890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bupropion-induced hypomania in a patient with unipolar depression.
    Hussain H; Butt MA
    Aust N Z J Psychiatry; 2008 Aug; 42(8):746. PubMed ID: 18622783
    [No Abstract]   [Full Text] [Related]  

  • 17. Subcortical nuclei volumetry in idiopathic generalized epilepsy.
    Seeck M; Dreifuss S; Lantz G; Jallon P; Foletti G; Despland PA; Delavelle J; Lazeyras F
    Epilepsia; 2005 Oct; 46(10):1642-5. PubMed ID: 16190937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paroxetine/bupropion combination treatment for refractory depression.
    Marshall RD; Liebowitz MR
    J Clin Psychopharmacol; 1996 Feb; 16(1):80-1. PubMed ID: 8834426
    [No Abstract]   [Full Text] [Related]  

  • 19. Bupropion-tranylcypromine combination for treatment-refractory depression.
    Pierre JM; Gitlin MJ
    J Clin Psychiatry; 2000 Jun; 61(6):450-1. PubMed ID: 10901349
    [No Abstract]   [Full Text] [Related]  

  • 20. Putamen hypertrophy in nondemented patients with human immunodeficiency virus infection and cognitive compromise.
    Castelo JM; Courtney MG; Melrose RJ; Stern CE
    Arch Neurol; 2007 Sep; 64(9):1275-80. PubMed ID: 17846265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.